You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

S-1,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)

Recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • Chemotherapy Effect
  • Hanzhou, Zhejiang, China
    Gastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023

Neuroendocrine Tumors Trial in Beijing (Surufatinib Combined With Temozolomide and S-1)

Not yet recruiting
  • Neuroendocrine Tumors
  • Surufatinib Combined With Temozolomide and S-1
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 8, 2023

NSCLC Trial in Singapore (Oral S-1 + Oral Osimertinib)

Not yet recruiting
  • NSCLC
  • Oral S-1 + Oral Osimertinib
  • Singapore, Singapore
    National Cancer Center Singapore
Mar 6, 2023

Gastric Cancer Trial in Tianjin (AK104, Apatinib, Paclitaxel)

Recruiting
  • Gastric Cancer
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
May 7, 2023

Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Advanced Solid Tumor
  • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
  • Tegafur Only Product
  • Petaling Jaya, Kuala Lumpur, Malaysia
    Clinical Oncology Department, Ummc
Jul 12, 2023

Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With

Recruiting
  • Gastric Cancer
  • +2 more
  • Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
  • Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 18, 2023

Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)

Recruiting
  • Esophageal Carcinoma
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 20, 2023

MS Patients Treated With Sphingosine-1-phosphate Receptor

Recruiting
  • Multiple Sclerosis
  • S1PR analysis on immune cells
  • Bern, Switzerland
    Neurology department
Apr 12, 2023

Locally Advanced Gastric Carcinoma Trial in Hanzhou (Oxaliplatin by arterial infusion plus S-1, SOX neoadjuvant, gastrectomy

Not yet recruiting
  • Locally Advanced Gastric Carcinoma
  • Oxaliplatin by arterial infusion plus S-1
  • +3 more
  • Hanzhou, Zhejiang, China
    Gastrointestinal Department of Second Affiliated Hospital of Zhe
Oct 20, 2022

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

S1 Transforaminal Epidural Block Trial (Tuohy needle group, Quincke needle group)

Not yet recruiting
  • S1 Transforaminal Epidural Block
  • Tuohy needle group
  • Quincke needle group
  • (no location specified)
Jul 2, 2023

COVID-19 Pneumonia Trial in Tunis (NANOS1 , argent colloïdal ,)

Completed
  • COVID-19 Pneumonia
  • NANOS1 , argent colloïdal ,
  • Tunis, Tunisia
    Agili Faida
Apr 19, 2023

Stomach Cancer Trial in Seoul (S-1 (452500ACH), OXALIPLATIN (205803BIJ))

Terminated
  • Stomach Cancer
  • S-1 (452500ACH)
  • OXALIPLATIN (205803BIJ)
  • Seoul, Korea, Republic of
    Kangbuk Samsung Hospital
Dec 6, 2022

Esophageal Squamous Cell Carcinoma Trial in Beijing (Fruquintinib in Combination with S-1)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Fruquintinib in Combination with S-1
  • Beijing, China
    Peking Union Medical College Hospital
Dec 2, 2022

Lumbosacral Radiculopathy Trial in Istanbul (Transforaminal epidural steroid injection, Caudal epidural steroid injection)

Active, not recruiting
  • Lumbosacral Radiculopathy
  • Transforaminal epidural steroid injection
  • Caudal epidural steroid injection
  • Istanbul, Pendik, Turkey
    Marmara University School of Medicine
Feb 1, 2023

Gastric Cancer Trial (Disitamab Vedotin, Sintilimab, S-1)

Not yet recruiting
  • Gastric Cancer
  • Disitamab Vedotin
  • +3 more
  • (no location specified)
Nov 17, 2022

Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)

Not yet recruiting
  • Immunotherapy Gastrict Cancer
  • (no location specified)
Jan 17, 2023

Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-415S1)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Shanghai, Shanghai, China
    Zhongshan Hospital Fudan University
May 23, 2023

Healthy Trial in Zurich (Robot-assisted US Scan of the vertebra L1 to S1, Handheld US scan of the vertebra L1 to S1, ULD CT scan

Completed
  • Healthy
  • Robot-assisted US Scan of the vertebra L1 to S1
  • +2 more
  • Zurich, Switzerland
    University Hospital Balgrist, Balgrist Campus
Jun 21, 2023

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Moderately hypofractionated conformal radiation combined With S-1)

Completed
  • Esophageal Squamous Cell Carcinoma
  • Moderately hypofractionated conformal radiation combined With S-1
  • Guangzhou, Guangdong, China
    Hui Liu
Oct 25, 2022

Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023

S1 Transforaminal Epidural Injection Trial in Daegu (needle type)

Recruiting
  • S1 Transforaminal Epidural Injection
  • needle type
  • Daegu, Korea, Republic of
    Kyungpook National University Hospital
Jul 13, 2023

Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • COVID-19 Infection
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • Shanghai, China
    Huashan hospital
Aug 16, 2022